Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: herceptin|DRUG: carboplatin|DRUG: docetaxel|PROCEDURE: conventional surgery|PROCEDURE: radiation therapy
Sponsor: University of Medicine and Dentistry of New Jersey
Collaborators: National Cancer Institute (NCI)|Aventis Pharmaceuticals